Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Overlapping Neuroimmune Mechanisms and Therapeutic Targets in Neurodegenerative Disorders.
De Marchi F, Munitic I, Vidatic L, Papić E, Rački V, Nimac J, Jurak I, Novotni G, Rogelj B, Vuletic V, Liscic RM, Cannon JR, Buratti E, Mazzini L, Hecimovic S. De Marchi F, et al. Among authors: mazzini l. Biomedicines. 2023 Oct 14;11(10):2793. doi: 10.3390/biomedicines11102793. Biomedicines. 2023. PMID: 37893165 Free PMC article. Review.
Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder.
De Marchi F, Franjkic T, Schito P, Russo T, Nimac J, Chami AA, Mele A, Vidatic L, Kriz J, Julien JP, Apic G, Russell RB, Rogelj B, Cannon JR, Baralle M, Agosta F, Hecimovic S, Mazzini L, Buratti E, Munitic I. De Marchi F, et al. Among authors: mazzini l. Biomedicines. 2023 May 31;11(6):1599. doi: 10.3390/biomedicines11061599. Biomedicines. 2023. PMID: 37371694 Free PMC article. Review.
Cell therapy in ALS: An update on preclinical and clinical studies.
Sironi F, De Marchi F, Mazzini L, Bendotti C. Sironi F, et al. Among authors: mazzini l. Brain Res Bull. 2023 Mar;194:64-81. doi: 10.1016/j.brainresbull.2023.01.008. Epub 2023 Jan 20. Brain Res Bull. 2023. PMID: 36690163 Free article. Review.
Sex Differences in Amyotrophic Lateral Sclerosis Survival and Progression: A Multidimensional Analysis.
Grassano M, Moglia C, Palumbo F, Koumantakis E, Cugnasco P, Callegaro S, Canosa A, Manera U, Vasta R, De Mattei F, Matteoni E, Fuda G, Salamone P, Marchese G, Casale F, De Marchi F, Mazzini L, Mora G, Calvo A, Chiò A. Grassano M, et al. Among authors: mazzini l. Ann Neurol. 2024 Apr 3. doi: 10.1002/ana.26933. Online ahead of print. Ann Neurol. 2024. PMID: 38568048
Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis.
Manak M, Gagnon L, Phay-Tran S, Levesque-Damphousse P, Fabie A, Daugan M, Khan ST, Proud P, Hussey B, Knott D, Charlton S, Hallis B, Medigeshi GR, Garg N, Anantharaj A, Raqib R, Sarker P, Alam MM, Rahman M, Murreddu M, Balgobind A, Hofman R, Grappi S, Coluccio R, Calandro P, Montomoli E, Mattiuzzo G, Prior S, Le Duff Y, Page M, Mitchell J, Schwartz LM, Bartsch YC, Azizi A, Bernasconi V; CEPI CLN Study Group. Manak M, et al. Lancet Microbe. 2024 Mar;5(3):e216-e225. doi: 10.1016/S2666-5247(23)00324-5. Epub 2024 Jan 23. Lancet Microbe. 2024. PMID: 38278167 Free article.
Correction to: Retrospective observational study on the use of acetyl-L-carnitine in ALS.
Sassi S, Bianchi E, Diamanti L, Tornabene D, Sette E, Medici D, Matà S, Leccese D, Sperti M, Martinelli I, Ghezzi A, Mandrioli J, Iuzzolino VV, Dubbioso R, Trojsi F, Passaniti C, D'Alvano G, Filosto M, Padovani A, Mazzini L, De Marchi F, Zinno L, Nuredini A, Bongioanni P, Dolciotti C, Canali E, Toschi G, Petrucci A, Perna A, Riso V, Inghilleri M, Libonati L, Cambieri C, Pupillo E. Sassi S, et al. Among authors: mazzini l. J Neurol. 2023 Nov;270(11):5358-5359. doi: 10.1007/s00415-023-11960-3. J Neurol. 2023. PMID: 37682317 Free PMC article. No abstract available.
234 results